CoChat
Sign Up
Cited by 155Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional DevelopmentAutism Spectrum Disorder Research

The DOI matches its Crossref record; 40 of the 43 references it cites were found in a registry or an index.

Association of psychiatric comorbidity with the risk of premature death among children and adults with attention-deficit/hyperactivity disorder.

Open access
Sun, Shihua, Kuja-Halkola, Ralf, Faraone, Stephen V., D’Onofrio, Brian M., Dalsgaard, Søren, Chang, Zheng, Larsson, Henrik·2019·JAMA Psychiatry
DOI 10.1001/jamapsychiatry.2019.1944PMC PMC6686979
Open this paper in CoChat — free accountOpen PDF

Abstract

Importance: A previous register-based study reported elevated all-cause mortality in attention-deficit/hyperactivity disorder (ADHD), but cause-specific risks and the potential associations of psychiatric comorbidities remain unknown. Objectives: To investigate the all-cause and cause-specific mortality risks in ADHD and to explore the potential role of psychiatric comorbidities. Design, Setting, and Participants: This prospective cohort study used Swedish national registers to identify 2 675 615 individuals born in Sweden from January 1, 1983, through December 31, 2009, as the study population, among whom 86 670 individuals (3.2%) received a diagnosis of ADHD during follow-up. Follow-up was completed December 31, 2013, and data were analyzed from October 2018 through March 2019. Exposures: Attention-deficit/hyperactivity disorder identified by first clinical diagnosis or first prescription of ADHD medications as recorded in Swedish registers. Clinical diagnosis of psychiatric comorbidity was available in the National Patient Register. Main Outcomes and Measures: All-cause and cause-specific mortalities and hazard ratios (HRs) using Cox proportional hazards regression models. Results: In the overall cohort of 2 675 615 individuals, 1 374 790 (51.4%) were male (57 919 with an ADHD diagnosis) and 1 300 825 (48.6%) were female (28 751 with an ADHD diagnosis). Mean (SD) age at study entry was 6.4 (5.6) years. During follow-up, 424 individuals with ADHD and 6231 without ADHD died, resulting in mortality rates of 11.57 and 2.16 per 10 000 person-years, respectively. The association was stronger in adulthood (HR, 4.64; 95% CI, 4.11-5.25) compared with childhood (HR, 1.41; 95% CI, 0.97-2.04) and increased substantially with the number of psychiatric comorbidities with ADHD (HR for individuals with only ADHD, 1.41 [95% CI, 1.01-1.97]; HR for those with ≥4 comorbidities, 25.22 [95% CI, 19.60-32.46]). In adulthood, when adjusting for early-onset psychiatric comorbidity, the association between ADHD and risk of death due to natural causes was attenuated substantially and was no longer statistically significant (HR, 1.32; 95% CI, 0.94-1.85). When adjusting for later-onset psychiatric disorders, the association was attenuated to statistical nonsignificance for death due to suicide (HR, 1.13; 95% CI, 0.88-1.45) but remained statistically significant for death caused by unintentional injury (HR, 2.14; 95% CI, 1.71-2.68) or other external causes (HR, 1.75; 95% CI, 1.23-2.48). Conclusions and Relevance: Psychiatric comorbidity appears to play an important role in all-cause and cause-specific mortality risks in ADHD. In adulthood, early-onset psychiatric comorbidity contributed primarily to the association with death due to natural causes, whereas later-onset psychiatric comorbidity mainly influenced death due to unnatural causes, including suicide and unintentional injury. These findings suggest that health care professionals should closely monitor specific psychiatric comorbidities in individuals with ADHD to identify high-risk groups for prevention efforts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapsychiatry.2019.1944

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 43 references

3 of the 43 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Larochette, 2009, Comorbid ADHD and depression in adults: additive effects on neurocognition., Arch Clin Neuropsychol, 24, 510

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Sun, S., Kuja-Halkola, R., Faraone, S. V., D’Onofrio, B. M., Dalsgaard, S., Chang, Z., & Larsson, H.
Affiliations
  • Karolinska Institutet (SE)
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  • SUNY Upstate Medical University (US)
  • Aarhus University (DK)
  • Örebro University (SE)
Corresponding author
Sun, Shihua
ORCID
Venue
JAMA Psychiatry
Publisher
American Medical Association (AMA)
Published
2019-11-01
Volume
76
Issue
11
Pages
1141
ISSN
2168-622X (ISSN-L)
DOI
10.1001/jamapsychiatry.2019.1944
PMC
PMC6686979
OpenAlex
W2966248724
Cited by
155
References
43
Citations by year
2026: 21 · 2025: 17 · 2024: 36 · 2023: 24 · 2022: 28 · 2021: 19 · 2020: 10
FWCI
11.35
Type
journal article
Language
en
Open access
Locations
  • JAMA Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Foundation for Suicide Prevention
  • European Commission (667302)
  • Lundbeckfonden (R248‐2017‐2003)
  • Vetenskapsrådet
  • Novo Nordisk Fonden (NNF 16OC0022018)
  • National Institutes of Health
  • National Institute of Mental Health (R01MH102221)
  • National Institute of Environmental Health Sciences (R01ES026993)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
attention deficit hyperactivity disorder, psychiatric comorbidity, premature mortality, cause-specific mortality, all-cause mortality, childhood ADHD, adult ADHD, comorbidity burden, cardiovascular mortality, cancer mortality, suicide, substance use disorders, psychiatric hospitalization, socioeconomic status, Sweden, register-based cohort study
MeSH terms
Adolescent, Adult, Attention Deficit Disorder with Hyperactivity, Mental Disorders, Child, Child, Preschool, Female, Humans, Infant, Male, Prospective Studies, Registries, Sweden, Comorbidity, Young Adult, Mortality, Premature

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review